We are live on ! Find out more
LCP

Legacy Capital Partners Portfolio holdings

AUM $304M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+20.42%
3 Year Est. Return
+85.6%
5 Year Est. Return
+136.75%
10 Year Est. Return
AUM
$161M
AUM Growth
+$5.63M
Cap. Flow
+$787K
Cap. Flow %
0.49%
Top 10 Hldgs %
27.76%
Holding
118
New
7
Increased
34
Reduced
56
Closed
5

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$840K
2
AMGN icon
Amgen
AMGN
+$816K
3
ABBV icon
AbbVie
ABBV
+$678K
4
ETN icon
Eaton
ETN
+$664K
5
AFL icon
Aflac
AFL
+$471K

Top Sells

Rank Stock Value
1
ITC
ITC HOLDINGS CORP
ITC
+$725K
2
VRSN icon
VeriSign
VRSN
+$628K
3
UTHR icon
United Therapeutics
UTHR
+$602K
4
FE icon
FirstEnergy
FE
+$361K
5
MO icon
Altria Group
MO
+$335K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.53%
2 Healthcare 18.13%
3 Technology 16.01%
4 Industrials 12.11%
5 Financials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
51
Hershey
HSY
$37.3B
$1.12M 0.7%
9,900
EFX icon
52
Equifax
EFX
$22B
$1.1M 0.69%
8,600
+250
+3% +$30.3K
LMT icon
53
Lockheed Martin
LMT
$133B
$1.1M 0.69%
4,440
+655
+17% +$154K
LYB icon
54
LyondellBasell Industries
LYB
$19.6B
$1.07M 0.67%
14,368
-2,290
-14% -$189K
BIV icon
55
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$956K 0.59%
10,848
+953
+10% +$82.4K
APC
56
DELISTED
Anadarko Petroleum
APC
$946K 0.59%
17,765
-390
-2% -$19.8K
UNH icon
57
UnitedHealth
UNH
$386B
$873K 0.54%
6,180
+900
+17% +$120K
EG icon
58
Everest Group
EG
$15.6B
$831K 0.52%
4,545
-850
-16% -$156K
AMGN icon
59
Amgen
AMGN
$210B
$799K 0.5%
+5,250
New +$816K
PCRX icon
60
Pacira BioSciences
PCRX
$1.04B
$783K 0.49%
23,200
+100
+0.4% +$4.92K
TGT icon
61
Target
TGT
$66.8B
$782K 0.49%
11,190
+310
+3% +$23.1K
HON icon
62
Honeywell
HON
$77.3B
$742K 0.46%
7,095
+700
+11% +$71.9K
POT
63
DELISTED
Potash Corp Of Saskatchewan
POT
$732K 0.46%
45,025
-2,100
-4% -$35.1K
WBA
64
DELISTED
Walgreens Boots Alliance
WBA
$696K 0.43%
8,350
+2,700
+48% +$218K
RTN
65
DELISTED
Raytheon Company
RTN
$671K 0.42%
4,929
+2,450
+99% +$319K
BMY icon
66
Bristol-Myers Squibb
BMY
$130B
$624K 0.39%
8,482
-368
-4% -$26K
DNP icon
67
DNP Select Income Fund
DNP
$4.15B
$608K 0.38%
57,200
+4,200
+8% +$43K
OXY icon
68
Occidental Petroleum
OXY
$55.7B
$604K 0.38%
7,984
+780
+11% +$58.3K
USB icon
69
US Bancorp
USB
$98.7B
$584K 0.36%
14,477
-1,225
-8% -$51K
BSV icon
70
Vanguard Short-Term Bond ETF
BSV
$44.7B
$555K 0.35%
6,842
-765
-10% -$61.7K
DE icon
71
Deere & Co
DE
$166B
$541K 0.34%
6,670
-3,050
-31% -$250K
MSFT icon
72
Microsoft
MSFT
$2.96T
$537K 0.33%
10,490
+270
+3% +$14K
CRI icon
73
Carter's
CRI
$1.42B
$530K 0.33%
4,975
-200
-4% -$20.6K
HCSG icon
74
Healthcare Services Group
HCSG
$1.61B
$522K 0.32%
12,600
CEF icon
75
Sprott Physical Gold and Silver Trust
CEF
$7.54B
$500K 0.31%
35,900

Similar funds

Legacy Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Legacy Capital Partners held 118 positions worth $161M, up 3.6% from $155M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Legacy Capital Partners's Q2 2016 filing shows 7 new, 34 increased, 56 reduced and 5 closed positions. Its largest new stake was Amgen: 5,250 shares worth $799K. The largest sale was ITC HOLDINGS CORP, an estimated $725K.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Legacy Capital Partners's largest Q2 2016 buy was Amgen: 5,250 shares worth $799K.
  • Legacy Capital Partners added most to Cisco in Q2 2016, an estimated $840K increase.
  • Legacy Capital Partners's biggest Q2 2016 reduction was Altria Group, cutting an estimated $335K.
  • Legacy Capital Partners fully exited ITC HOLDINGS CORP in Q2 2016, selling an estimated $725K.
  • Legacy Capital Partners's ten largest holdings make up 28% of its $161M portfolio in Q2 2016.
  • Legacy Capital Partners opened 7 new positions and closed 5 in Q2 2016.
  • Legacy Capital Partners's portfolio value rose 3.6% quarter-over-quarter to $161M.

Based on Legacy Capital Partners's 13F filing for Q2 2016, filed 9 Aug 2016.